Dems' 'Better Deal' Would Create Drug Price Gouging 'Enforcer'
Executive Summary
Plan would empower new agency to investigate and potentially fine drug manufacturers that make unjustified price increases.
You may also be interested in...
Generic Industry Sues To Halt Maryland's 'Price Gouging' Law
Association for Accessible Medicines says sweeping price restraints on off-patent and generic drugs are vague and will 'unleash a potentially unlimited number of enforcement actions.'
FDA Drug Pricing Policy Offers Short-Term PR Gain, More Long-Term Actual Benefit
Prioritizing ANDAs entering markets with fewer than three approved generics not expected to become a major advantage until first-cycle clearances increase.
The Bully Pulpit: Trump Versus Drug Prices
Medicare price negotiation is not a new idea – nor is the concept of using the Presidential megaphone to talk down drug prices. Will Trump and Twitter turn it into something bigger?